FiercePharma

Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone

ABBOTT PARK, Ill., April 29, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved AndroGel® (testosterone gel) 1.62%, a clear, odorless ...
Medscape

First-Time Generic Approvals: Flexeril, Plavix, and AndroGel

Feb. 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of cyclobenzaprine HCl 5-mg tablets for adjunctive use in the short-term treatment of muscle ...
Nature

Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function

The purpose of the present study was to evaluate the efficacy and safety of 50 mg/day of TTG, applied on non-scrotal skin, for hypogonadal men in Taiwan. Although TTG has been shown to be effective in ...
Drug Store News

FDA gives Alembic tentative OK for generic AndroGel

Adult males who have conditions associated with a deficiency or absence of endogenous testosterone will soon have a new generic treatment, pending the Food and Drug Administration’s final approval.